|
Report Date : |
10.02.2014 |
IDENTIFICATION DETAILS
|
Name : |
PHILCO
PHARMA - CARSTEN PHILIPPS (E.K.) |
|
|
|
|
Registered Office : |
Barkholt
63-65 D 22927 Großhansdorf |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
20.04.2001 |
|
|
|
|
Legal Form : |
Sole
proprietorship |
|
|
|
|
Line of Business : |
Wholesale
of pharmaceutical, medical and orthpedic goods |
|
|
|
|
No. of Employees : |
10 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC
OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth in 2006 and 2007 and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 6.5% in 2012. GDP contracted 5.1% in 2009 but grew by 4.2% in 2010, and 3.0% in 2011, before dipping to 0.7% in 2012 - a reflection of low investment spending due to crisis-induced uncertainty and the decreased demand for German exports from recession-stricken periphery countries. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011. In 2012 Germany reached a budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. By 2014, the federal government wants to balance its budget. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela Merkel announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production
|
Source
: CIA |
PHILCO PHARMA - CARSTEN PHILIPPS
(E.K.)
Company Status: active
Barkholt 63-65
D 22927 Großhansdorf
Telephone:04102/695219
Telefax: 04102/695264
Homepage: www.philcopharma.de
E-mail: philcopharma@aol.com
VAT no.: DE216347601
Business relations are permissible.
LEGAL FORM Sole
proprietorship
Date of foundation: 2001
Begin of business
activities: 20.04.2001
Registered on: 20.04.2001
Register of
companies: Local
court 23568 Lübeck
under: HRA 3219 AH
Proprietor:
Carsten Philipps
D 22926 Ahrensburg
born: 01.04.1962
Profession: Businessman
Main industrial sector
4646 Wholesale
of pharmaceutical, medical and orthpedic goods
Payment
experience: within agreed terms
Negative information: We have no negative
information at hand.
Type of ownership: Tenant
Address Barkholt 63-65
D 22927 Großhansdorf
Land register documents were not available.
COMMERZBANK, HAMBURG
Sort. code: 20040000, BIC: COBADEHHXXX
HAMBURGER SPARKASSE, HAMBURG
Sort. code: 20050550, BIC: HASPDEHHXXX
Financial year: 01.01.
- 31.12.
Turnover: 2012 EUR 4,000,000.00
2013 EUR 10,000,000.00
Expected turnover: EUR
10,000,000.00
further business figures:
Equipment: *EUR 51,000.00
Ac/ts receivable: *EUR 59,500.00
Liabilities: *EUR 187,000.00
Total numbers of vehicles: 1
- Passenger cars: 1
Employees:
10
- Part-time employees: 3
The business figures marked with an asterisk
are estimates based on average values in the line of business.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.32 |
|
|
1 |
Rs.101.78 |
|
Euro |
1 |
Rs.84.68 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.